Science & Technology
Science and Technology
Science and Technology
Tue, December 22, 2009
Mon, December 21, 2009 
TAMPA, Fla.--([ BUSINESS WIRE ])--Bulova Technologies Group, Inc. (Pink Sheets:BLVT) ("BulovaTech" or "the Company") today provided an update regarding healthcare technologies contained in BulovaTech Labs.
As indicated in our 12/14/09 release, BulovaTech Labs contains certain technologies that the Company believes provide a foundation for substantial growth in the future. The purpose of this release is to provide an overview of the healthcare technologies prior to a more complete explanation that will be contained in our public filings.
The healthcare technologies relate to both the business and delivery of healthcare. The business technologies are in the areas of remote monitoring of patient data, and transmission of that data. BulovaTech acquired approximately 65% of Cyber Care, Inc. ("Cyber Care") through a plan of reorganization. Cyber Care developed "electronic house call," a patented remote patient monitoring system. We believe this family of technologies has significant military and civilian applications in the current healthcare environment. Cyber Care once had a substantial market presence based upon the promise of electronic house call. These technologies have been advanced during Cyber Care's reorganization and are now market-ready.
Technologies related to healthcare delivery focus on disease prevention, diagnosis and treatment. The areas of interest include soft tissue calcification, cancer and personalized immunotherapy. We believe the current healthcare environment places an emphasis on wellness and early stage disease diagnosis. Substantial sums have been expended in areas of interest to our Company. Shareholders can look forward to real advances in 2010.
As previously indicated we will preview Defense Technologies on December 28th.
John Stanton, Chairman
Stephen Gurba, President and CEO
About Bulova Technologies Group, Inc.
Headquartered in Clearwater, Florida, Bulova Technologies Group, Inc. operates two facilities, Bulova Technologies Ordnance Systems in Mayo, FL and BT Manufacturing Company in Melbourne, FL. The headquarters also houses BulovaTech Labs, Inc and Bulova Technologies Combat Systems Company which is a world leader in the international sale of military vehicles, weapons and munitions in support of the U.S. Department of Defense.
Investors are cautioned that certain statements contained in this document as well as some statements in periodic press releases and some oral statement of Bulova Technologies Group officials are "Forward-Looking Statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions, which include words such as "believes," "anticipates," "intends," "plans," "expects," and similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible future Bulova Technologies Group actions, which may be provided by management, are also forward-looking statements as defined by the Act. Forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements and to vary significantly from reporting period to reporting period. Although management believes that the assumptions made and expectations reflected in the forward-looking statements are reasonable, there is no assurance that the underlying assumptions will, in fact, prove to be correct or that actual future results will not be different from the expectations expressed in this report. These statements are not guarantees of future performance and Bulova Technologies Group has no specific intention to update these statements.
